Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line
- Authors
- Jung, Myung-Ho; Kim, Hwan; Choi, Won-Kyoung; El-Gamal, Mohammed I.; Park, Jin-Hun; Yoo, Kyung Ho; Sim, Tae Bo; Lee, So Ha; Baek, Daejin; Hah, Jung-Mi; Cho, Jung-Hyuck; Oh, Chang-Hyun
- Issue Date
- Dec-2009
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- Pyrrolo[2,3-d]pyrimidine; A375; HS 27; Antiproliferative activity; Melanoma
- Citation
- BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.19, no.23, pp.6538 - 6543
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Volume
- 19
- Number
- 23
- Start Page
- 6538
- End Page
- 6543
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/40611
- DOI
- 10.1016/j.bmcl.2009.10.051
- ISSN
- 0960-894X
- Abstract
- Synthesis of a new series of diarylureas and amides having pyrrolo[2,3-d]pyrimidine scaffold is described. Their in vitro antiproliferative activities against A375 human melanoma cell line and HS 27 fibroblast cell line were tested and the effect of substituents on pyrrolo[2,3-d]pyrimidine was investigated. The newly synthesized compounds, except N-acetyl derivatives (Id, Ie, and Im), generally showed superior or similar activity against A375 to Sorafenib. Among all of these derivatives, compounds Iq and Ir having imidazole and morpholine moieties, respectively, showed the most potent antiproliferative activity against A375. (C) 2009 Published by Elsevier Ltd.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.